More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or depression, according to study results.
Those symptoms correlated with reduced quality of life.
Oreofe O. Odejide, MD, MPH, associate professor of medicine at Dana-Farber Cancer Institute, and colleagues conducted a survey of 200 adults who had been diagnosed with lymphoma or myeloma in the prior 6 months.
Researchers used survey responses to characterize anxiety and depression. They used multivariable analyses to examine the relationship between anxiety or depression symptoms